Unexplained Infertility

Derbala Reproductive Immunology > Unexplained Infertility

Unexplained Infertility

Infertility is a unique medical condition affecting couples who are unable to conceive after 12 months of regular timed intercourse without the use of birth control method in women less than 35 years of age, and after 6 months of regular timed intercourse without the use of birth control method in women 35 years and older. The frequency of primary infertility by age groups was: 7.3 – 9.1% (from 15 to 34 years), 25% (from 35 to 39 years) and 30% (40 to 44 years).

Infertility

When all the standard fertility tests come back normal — ovulation is happening, the fallopian tubes are open, and the sperm analysis looks fine — doctors may diagnose what is called “unexplained infertility.” This accounts for up to 30% of all infertility cases. For many couples, this diagnosis can feel frustrating and confusing. However, a growing field called reproductive immunology is shedding new light on why some couples struggle to conceive, even when everything appears normal on paper.

Your Immune System Plays a Bigger Role Than You Might Think

Most people think of the immune system as the body’s defense against infections. But the immune system also plays a critical role in pregnancy — starting from the very first moment an embryo tries to attach to the lining of the uterus (a process called implantation). For a pregnancy to succeed, the mother’s immune system must recognize the embryo — which carries genetic material from both parents — and choose to protect it rather than reject it. This delicate balance between acceptance and defense is orchestrated by specialized immune cells and chemical messengers in the uterus.

When this immune balance is disrupted, the embryo may fail to implant properly, or an early pregnancy may be lost before a woman even knows she is pregnant. This is one of the hidden causes behind many cases of unexplained infertility.

Natural Killer Cells: Protectors, Not Just Fighters

One of the most studied immune factors in reproductive immunology is a type of white blood cell called a natural killer (NK) cell. Despite their intimidating name, uterine NK cells are not there to attack the embryo. In fact, they are essential helpers. Uterine NK cells assist with remodeling the blood vessels in the uterine lining, helping to establish a healthy blood supply to the developing placenta. They also help guide the embryo as it burrows into the uterine wall during implantation.

Problems arise when these NK cells (in blood and uterus)  are present in abnormal numbers or when their activity is too high or too low. Research has shown that women with recurrent implantation failure — meaning repeated unsuccessful embryo transfers during IVF — often have altered NK cell profiles compared to women who conceive successfully. Some studies have found that certain receptors on NK cells are expressed differently in women with reproductive failure, which may impair the critical communication between the mother’s immune cells and the embryo.

Peripheral blood natural killer cells (pNK cells) are a type of immune cell found in your bloodstream. While they are related to the NK cells in your uterus, they have different jobs and properties. In reproductive immunology, there is ongoing research into whether the number or activity level of these pNK cells in the blood can help explain infertility. Some studies have found that women with unexplained infertility tend to have a higher percentage of pNK cells in their blood or that these cells show signs of being highly “activated.” This suggests that an overactive immune response throughout the body, reflected in the blood, might be contributing to problems with conception or implantation. However, it is important to know that pNK cells in the blood do not always accurately reflect what is happening with the NK cells right inside the uterus. For this reason, while testing for pNK cell numbers or activity is sometimes part of a specialized evaluation, its value in predicting pregnancy success is still debated by experts and should be interpreted by a reproductive immunology specialist.

The Th1/Th2 Balance: A Delicate Immune Shift

Another important concept in reproductive immunology involves two types of immune responses known as Th1 and Th2. Th1 responses are pro-inflammatory — they fight infections and foreign invaders. Th2 responses are anti-inflammatory — they calm the immune system down and promote tolerance.

During a healthy pregnancy, the body naturally shifts toward a Th2-dominant state, especially after implantation. This shift helps protect the embryo from being attacked by the mother’s immune system. However, in some women with unexplained infertility or recurrent implantation failure, this shift does not happen properly. Instead, the Th1 response remains too strong, creating an inflammatory environment in the uterus that can prevent the embryo from implanting or surviving. Studies have confirmed that elevated levels of pro-inflammatory cytokines (immune signaling molecules) and an increased Th1/Th2 ratio are associated with implantation failure.

Regulatory T Cells: The Peacekeepers

Regulatory T cells (often called Tregs) are another key player. These cells act as peacekeepers of the immune system — they suppress excessive immune reactions and help maintain tolerance toward the embryo. In a healthy pregnancy, Tregs increase in number at the site where the embryo implants, helping to create a welcoming environment. Women with recurrent pregnancy loss or implantation failure may have fewer or less effective Tregs, which can tip the immune balance toward rejection.

Autoimmune Factors and Hidden Antibodies

Reproductive immunology has also uncovered the role of autoimmune factors in unexplained infertility. Certain antibodies — proteins made by the immune system that normally target infections — can sometimes mistakenly target the body’s own tissues, including reproductive tissues.

Antiphospholipid antibodies are among the most well-studied. These antibodies can interfere with blood flow to the placenta and increase the risk of implantation failure and miscarriage. Testing for antiphospholipid antibodies is now recommended by major medical societies for women with recurrent pregnancy loss.

Thyroid autoimmunity is another important factor. Even when thyroid hormone levels are normal, the presence of anti-thyroid antibodies (such as anti-TPO antibodies) has been linked to a higher risk of unexplained infertility and miscarriage. These antibodies may reflect a broader tendency toward immune dysregulation that affects the uterine environment.

What This Means for You

If you have been diagnosed with unexplained infertility, it does not necessarily mean that nothing is wrong — it may mean that the right tests have not yet been done. Reproductive immunology offers a deeper look at what may be happening beneath the surface. Specialized testing can evaluate NK cell activity, cytokine profiles and autoimmune antibodies to identify treatable immune-related causes.

Treatment options are evolving and may include immunomodulatory therapies such as Intravenous immunoglobulin (IVIG), prednisone, Plaquenil, Tacrolimus, Lovenox, low-dose aspirin and Progesterone support to promote a healthy immune shift. 

It is important to note that while the science is promising, many of these treatments are still being refined. Not every patient with unexplained infertility has an immune-related cause, and treatment should always be guided by proper testing and an experienced specialist. The field of reproductive immunology is advancing rapidly, and what was once labeled “unexplained” is increasingly becoming explainable — and treatable.

 

References:

  1. Carson SA, Kallen AN. Diagnosis and Management of Infertility: A Review. JAMA. 2021;326(1):65-76. doi:10.1001/jama.2021.4788
  2. Evidence-Based Treatments for Couples With Unexplained Infertility: A Guideline. Fertility and Sterility. 2020;113(2):305-322. doi:10.1016/j.fertnstert.2019.10.014
  3. Phillips K, Olanrewaju RA, Omole F. Infertility: Evaluation and Management. American Family Physician. 2023;107(6):623-630. PMID:37327165
  4. Sunkara SK, Kamath MS, Pandian Z, Gibreel A, Bhattacharya S. In Vitro Fertilisation for Unexplained Subfertility. Cochrane Database of Systematic Reviews. 2023;9:CD003357. doi:10.1002/14651858.CD003357.pub5
  5. Wang R, Danhof NA, Tjon-Kon-Fat RI, et al. Interventions for Unexplained Infertility: A Systematic Review and Network Meta-Analysis. Cochrane Database of Systematic Reviews. 2019;9:CD012692. doi:10.1002/14651858.CD012692.pub2
  6. Penzias A, Azziz R, Bendikson K, et al. Optimizing Natural Fertility: A Committee Opinion. Fertility and Sterility. 2022;117(1):53-63. doi:10.1016/j.fertnstert.2021.10.007
  7. Wesselink AK, Rothman KJ, Hatch EE, et al. Age and Fecundability in a North American Preconception Cohort Study. American Journal of Obstetrics and Gynecology. 2017;217(6):667.e1-667.e8. doi:10.1016/j.ajog.2017.09.002
  8. Liang Y, Huang J, Zhao Q, et al. Global, Regional, and National Prevalence and Trends of Infertility Among Individuals of Reproductive Age (15-49 Years) From 1990 to 2021, With Projections to 2040. Human Reproduction. 2025;40(3):529-544. doi:10.1093/humrep/deae292
  9. Liu J, Qin Y, Liu H, et al. Global, Regional, and National Burden of Female Infertility and Trends From 1990 to 2021 With Projections to 2050 Based on the GBD 2021 Analysis. Scientific Reports. 2025;15(1):17559. doi:10.1038/s41598-025-01498-x
  10. Robertson SA, Moldenhauer LM, Green ES, Care AS, Hull ML. Immune Determinants of Endometrial Receptivity: A Biological Perspective. Fertility and Sterility. 2022;117(6):1107-1120. doi:10.1016/j.fertnstert.2022.04.023
  11. Robertson SA, Care AS, Moldenhauer LM. Regulatory T Cells in Embryo Implantation and the Immune Response to Pregnancy. The Journal of Clinical Investigation. 2018;128(10):4224-4235. doi:10.1172/JCI122182
  12. Liu H, Huang W, Hu Z, et al. Regulatory T Cells in Human Pregnancy: Mechanisms, Dysregulation, and Therapeutic Perspectives. Frontiers in Immunology. 2026;17:1815957. doi:10.3389/fimmu.2026.1815957
  13. Huang N, Chi H, Qiao J. Role of Regulatory T Cells in Regulating Fetal-Maternal Immune Tolerance in Healthy Pregnancies and Reproductive Diseases. Frontiers in Immunology. 2020;11:1023. doi:10.3389/fimmu.2020.01023
  14. Luo L, Zeng X, Huang Z, et al. Reduced Frequency and Functional Defects of CD4+CD25+CD127low/- Regulatory T Cells in Patients With Unexplained Recurrent Spontaneous Abortion. Reproductive Biology and Endocrinology. 2020;18(1):62. doi:10.1186/s12958-020-00619-7
  15. Berdiaki A, Vergadi E, Makrygiannakis F, Vrekoussis T, Makrigiannakis A. Repeated Implantation Failure Is Associated With Increased Th17/Treg Cell Ratio, During the Secretory Phase of the Human Endometrium. Journal of Reproductive Immunology. 2024;161:104170. doi:10.1016/j.jri.2023.104170
  16. Seshadri S, Sunkara SK. Natural Killer Cells in Female Infertility and Recurrent Miscarriage: A Systematic Review and Meta-Analysis. Human Reproduction Update. 2014;20(3):429-438. doi:10.1093/humupd/dmt056
  17. Tang AW, Alfirevic Z, Quenby S. Natural Killer Cells and Pregnancy Outcomes in Women With Recurrent Miscarriage and Infertility: A Systematic Review. Human Reproduction. 2011;26(8):1971-1980. doi:10.1093/humrep/der164
  18. Ou M, Luo L, Yang Y, et al. Decrease in Peripheral Natural Killer Cell Level During Early Pregnancy Predicts Live Birth Among Women With Unexplained Recurrent Pregnancy Loss: A Prospective Cohort Study. American Journal of Obstetrics and Gynecology. 2024;230(6):675.e1-675.e13. doi:10.1016/j.ajog.2023.10.042
  19. Salazar MD, Wang WJ, Skariah A, et al. Post-Hoc Evaluation of Peripheral Blood Natural Killer Cell Cytotoxicity in Predicting the Risk of Recurrent Pregnancy Losses and Repeated Implantation Failures. Journal of Reproductive Immunology. 2022;150:103487. doi:10.1016/j.jri.2022.103487
  20. Zhang Y, Yan X, Wu J, et al. Abnormal Expression of ILT2, NKG2D and NKp46 Receptors on Natural Killer Cells in Women With Unexplained Recurrent Implantation Failure. Journal of Reproductive Immunology. 2026;175:104885. doi:10.1016/j.jri.2026.104885
  21. Vomstein K, Egerup P, Kolte AM, et al. Biopsy-Free Profiling of the Uterine Immune System in Patients With Recurrent Pregnancy Loss and Unexplained Infertility. Reproductive Biomedicine Online. 2023;47(2):103207. doi:10.1016/j.rbmo.2023.03.018
  22. Guo L, Guo A, Yang F, et al. Alterations of Cytokine Profiles in Patients With Recurrent Implantation Failure. Frontiers in Endocrinology. 2022;13:949123. doi:10.3389/fendo.2022.949123
  23. Ozkan ZS, Deveci D, Kumbak B, et al. What Is the Impact of Th1/Th2 Ratio, SOCS3, IL17, and IL35 Levels in Unexplained Infertility? Journal of Reproductive Immunology. 2014;103:53-58. doi:10.1016/j.jri.2013.11.002
  24. Rai R, Regan L. Recurrent Miscarriage. Lancet. 2006;368(9535):601-611. doi:10.1016/S0140-6736(06)69204-0
  25. Deroux A, Dumestre-Perard C, Dunand-Faure C, Bouillet L, Hoffmann P. Female Infertility and Serum Auto-Antibodies: A Systematic Review. Clinical Reviews in Allergy & Immunology. 2017;53(1):78-86. doi:10.1007/s12016-016-8586-z
  26. Bellver J, Soares SR, Alvarez C, et al. The Role of Thrombophilia and Thyroid Autoimmunity in Unexplained Infertility, Implantation Failure and Recurrent Spontaneous Abortion. Human Reproduction. 2008;23(2):278-284. doi:10.1093/humrep/dem383
  27. El Hasbani G, Khamashta M, Uthman I. Antiphospholipid Syndrome and Infertility. Lupus. 2020;29(2):105-117. doi:10.1177/0961203319893763
  28. Krivonos MI, Khizroeva JKh, Zainulina MS, et al. The Role of Lymphocytic Cells in Infertility and Reproductive Failures in Women With Antiphospholipid Antibodies. The Journal of Maternal-Fetal & Neonatal Medicine. 2022;35(5):871-877. doi:10.1080/14767058.2020.1732343
  29. Versini M. Thyroid Autoimmunity and Antiphospholipid Syndrome: Not Such a Trivial Association. Frontiers in Endocrinology. 2017;8:175. doi:10.3389/fendo.2017.00175
  30. Radojcić L, Marjanović S, Vićovac L, Kataranovski M. Anticardiolipin Antibodies in Women With Unexplained Infertility. Physiological Research. 2004;53(1):91-96. PMID:14984319
  31. The Role of Immunotherapy in In Vitro Fertilization: A Guideline. Fertility and Sterility. 2018;110(3):387-400. doi:10.1016/j.fertnstert.2018.05.009
  32. Genest G, Banjar S, Almasri W, et al. Immunomodulation for Unexplained Recurrent Implantation Failure: Where Are We Now? Reproduction. 2023;165(2):R39-R60. doi:10.1530/REP-22-0150
  33. Meng S, Zhang T, Li C, Zhang X, Shen H. Immunoregulatory Therapy Improves Reproductive Outcomes in Elevated Th1/Th2 Women With Embryo Transfer Failure. BioMed Research International. 2022;2022:4990184. doi:10.1155/2022/4990184
  34. Ghasemnejad-Berenji H, Ghaffari Novin M, Hajshafiha M, et al. Immunomodulatory Effects of Hydroxychloroquine on Th1/Th2 Balance in Women With Repeated Implantation Failure. Biomedicine & Pharmacotherapy. 2018;107:1277-1285. doi:10.1016/j.biopha.2018.08.027
  35. Han DL, Li L, Shi J, et al. Hydroxychloroquine Sulfate Tablets for Patients With Recurrent Implantation Failure: A Double-Blind, Randomized, Placebo-Controlled Trial. Trials. 2026;10.1186/s13063-026-09470-4. doi:10.1186/s13063-026-09470-4
  36. Dernoncourt A, Hedhli K, Abisror N, et al. Hydroxychloroquine in Recurrent Pregnancy Loss: Data From a French Prospective Multicenter Registry. Human Reproduction. 2024;39(9):1934-1941. doi:10.1093/humrep/deae146
  37. Hisano M, Nakagawa K, Ono M, et al. Multicenter, 2-Dose Single-Group Controlled Trial of Tacrolimus for the Severe Infertility Patients. Medicine. 2023;102(32):e34317. doi:10.1097/MD.0000000000034317
  38. Abdolmohammadi-Vahid S, Danaii S, Hamdi K, et al. Novel Immunotherapeutic Approaches for Treatment of Infertility. Biomedicine & Pharmacotherapy. 2016;84:1449-1459. doi:10.1016/j.biopha.2016.10.062
  39. Aslanian-Kalkhoran L, Nouri N, Soltani-Zangbar MS, Mardi A, Aghebati-Maleki L. Immunoglobulin Therapy for Infertility and the Role of Immune Cells in Pregnancy Success: An Extensive Investigation and Update. Journal of Reproductive Immunology. 2025;169:104458. doi:10.1016/j.jri.2025.104458
  40. Nørgaard-Pedersen C, Nielsen K, Steffensen R, et al. Intravenous Immunoglobulin and Prednisolone to Women With Unexplained Recurrent Pregnancy Loss After Assisted Reproductive Technology Treatment: A Protocol for a Randomised, Double-Blind, Placebo-Controlled Trial. BMJ Open. 2022;12(9):e064780. doi:10.1136/bmjopen-2022-064780
  41. Yull S, Shafiei S, Park CB, et al. Uterine Nodal Expression Supports Maternal Immunotolerance and Establishment of the FOXP3+ Regulatory T Cell Population During the Preimplantation Period. Frontiers in Immunology. 2023;14:1276979. doi:10.3389/fimmu.2023.1276979
  42. Boxem AJ, Blaauwendraad SM, Mulders AGMGJ, et al. Age Among Women and Men, Time to Pregnancy and Risk of Miscarriage. BMC Medicine. 2025;23(1):639. doi:10.1186/s12916-025-04462-8
Back